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SIGN-R1, or CD209b, is a mouse C-type lectin receptor that is expressed at high
levels on macrophages in lymphoid tissues, especially within the marginal zone
of the spleen. SIGN-R1 can bind and mediate the uptake of various microbial
polysaccharides, including dextrans, lipopolysaccharides and pneumococcal
capsular polysaccharides. It has been shown that SIGN-R1 mediates the
clearance of encapsulated pneumococcus, complement fixation via binding C1q
independent of antibody and innate resistance to pneumococcal infection.
Recently, SIGN-R1 has also been demonstrated to bind sialylated antibody and
mediate its activity to suppress autoimmunity. The carbohydrate-recognition
domain (CRD) of SIGN-R1 has been cloned and overexpressed in a soluble
secretory form in mammalian Chinese hamster ovary (CHO) cells. The CRD
protein of SIGN-R1 was purified from CHO cell-culture supernatant and
concentrated for crystallization using the hanging-drop vapour-diffusion method
at 291 K. Crystals grew from a mixture of 2M ammonium sulfate in 0.1M bis-
tris pH 5.5. Single crystals, which belonged to the monoclinic space group C2
with unit-cell parameters a = 146.72, b = 92.77, c = 77.06 A˚,  = 121.66, allowed
the collection of a full X-ray data set to a maximum resolution of 1.87 A˚.
1. Introduction
Streptococcus pneumoniae is one of the most common and important
human pathogens and causes serious life-threatening diseases such as
acute otitis media, pneumonia, sepsis and meningitis. Pneumococcal
infections are associated with high morbidity and mortality, especially
amongst children, the elderly and immune-depressed patients. The
widespread emergence of antibiotic resistance and the lack of highly
effective pneumococcal vaccines against all serotypes of this
organism give urgency to the elucidation of the molecular processes
that are involved in its pathogenicity (Kristinsson, 1997; Pelton,
2000). Recognition of pathogens by the immune system is crucial for
the initiation and maintenance of protective immunity. Pattern-
recognition receptors, including C-type lectins and Toll-like receptors,
discriminate the molecular patterns expressed by pathogens and
facilitate differential recognition of pathogens and microbial products
(Gordon, 2002).
The innate immune responses provide a critical rapid defence
mechanism that acts before the maturation of acquired immunity.
Investigations have revealed that SIGN-R1, or CD209b, is a C-type
lectin receptor that is primarily found on subsets of macrophages in
splenic marginal zone and lymph-node medulla in mouse and
mediates the uptake of dextrans (Geijtenbeek et al., 2002; Kang et al.,
2003) and lipopolysaccharides (Nagaoka et al., 2005). Furthermore,
SIGN-R1 plays an essential role in host defence against S. pneumo-
niae by mediating the recognition of capsular polysaccharide and the
clearance of these bacteria (Kang et al., 2004; Park et al., 2009;
Lanoue et al., 2004). Moreover, SIGN-R1 contributes to innate
resistance by an unusual complement-activation pathway that is
independent of immunoglobulin (fulfilling the role of IgM) via direct
binding with C1q, an essential subcomponent of the classical com-
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plement pathway (Kang et al., 2006). Recently, SIGN-R1 has been
identified as a lectin receptor that is required for the anti-inflammatory
activity of intravenous sialylated immunoglobulin, suggesting that it
is a key player in the new therapeutic approach of using sialylated
immunoglobulin to suppress autoimmune diseases (Anthony et al.,
2008).
SIGN-R1, a C-type lectin receptor, has a structure consisting of
an N-terminal cytosolic domain, a single transmembrane domain, a
neck domain and a carbohydrate-recognition domain (CRD) at the
C-terminus. We generated and expressed in mammalian cells the
soluble form of the CRD part of SIGN-R1 (CRD_SIGN-R1), which
contains 134 amino-acid residues. Here, we describe the initial results
obtained for the crystallization of CRD_SIGN-R1 and its X-ray
diffraction data to 1.87 A˚ resolution.
2. Experimental procedures
2.1. Expression and purification of CRD_SIGN-R1
To produce a soluble secretory form of CRD_SIGN-R1 protein
tagged with a FLAG epitope, the sequences for a signal peptide and a
FLAG epitope were fused to the sequence of the CRD portion of
SIGN-R1. The construct of soluble FLAG-tagged CRD_SIGN-R1,
(SF-CRD_SIGN-R1; GenBank accession No. EU697459) was stably
transfected into Chinese hamster ovary (CHO) cells. SF-CRD_SIGN-
R1 protein was purified from the culture supernatant of CHO/SF-
CRD_SIGN-R1 cells using Anti-FLAG M1 Affinity Gel (Sigma–
Aldrich, St Louis, Missouri, USA) following the manufacturer’s
instructions. 1 mg of protein with a molecular weight of 16.5 kDa was
obtained at the end of the purification, which was further concen-
trated to 3.5 mg ml1 by centrifugation using an Amicon Ultra-10
membrane in 0.01M Tris–HCl pH 8 and 0.1M NaCl buffer.
2.2. Crystallization
Initial assays were carried out by the sitting-drop vapor-diffusion
method at 291 K on Innovaplate SD-2 microplates (Innovadyne
Technologies Inc.), mixing 250 nl protein solution with 250 nl
precipitant solution and equilibrating against 70 ml well solution.
High-throughput techniques with a NanoDrop robot (Innovadyne
Technologies Inc.) were used to assay crystallization conditions using
CRD_SIGN-R1 at 3.5 mg ml1 in 0.01M Tris–HCl pH 8 and 0.1M
NaCl with the PACT Suite and JCSG+ Suite from Qiagen and
JBScreen Classics 1, 4, 5 and 7 from Jena Bioscience. Successful initial
conditions were optimized by hand using hanging-drop methods,
mixing 1 ml protein solution with 1 ml precipitant solution and
equilibrating against 500 ml well solution.
2.3. X-ray data collection and processing
All crystals were soaked for 5 s in a cryosalt protective solution
consisting of 50%(v/v) saturated lithium sulfate in the crystallization
solution prior to flash-cooling to 100 K using a cryogenic system. A
native data set was collected using synchrotron radiation on beamline
ID23-1 at ESRF (Grenoble) using an ADSC Quantum Q315r
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Figure 1
CRD_SIGN-R1 crystals obtained using 1.7M ammonium sulfate and 0.1M bis-tris
pH 5.5. The approximate dimensions of the crystals were 0.06  0.06  0.01 mm.
Figure 2
(a) X-ray diffraction pattern of CRD_SIGN-R1 crystals (oscillation range 1.0); (b)
enlargement showing the highest resolution area.
detector and a wavelength of 1.072250 A˚. The collected images were
processed and scaled using MOSFLM (Leslie, 2006) and SCALA
(Collaborative Computational Project, Number 4, 1994), respectively.
3. Results
The CRD_SIGN-R1 microcrystals grew under six different condi-
tions. Four of these used ammonium sulfate as the main precipitant
agent: (i) 2M ammonium sulfate in 0.1M sodium acetate pH 4.6, (ii)
2M ammonium sulfate with 0.2M sodium chloride in 0.1M sodium
cacodylate pH 6.5, (iii) 2M ammonium sulfate in 0.1M Tris–HCl pH
8.5 and (iv) 2M ammonium sulfate in 0.1M bis-tris pH 5.5. The other
two conditions used different agents: (v) 2.1M dl-malonic acid pH 7
and (vi) 1.6M trisodium citrate. Good-quality crystals with a rhom-
bohedral shape were obtained using 2M ammonium sulfate in 0.1M
bis-tris pH 5.5. The crystals reached maximum dimensions of 0.06 
0.06  0.01 mm in two weeks (Fig. 1).
An X-ray data set was collected to 1.87 A˚ resolution from a single
CRD_SIGNR-1 crystal and displayed apparently weak but well
defined diffraction patterns (Fig. 2). X-ray data processing showed
good processing statistics (Table 1). The crystal belonged to the
monoclinic space group C2, with unit-cell parameters a = 146.72,
b = 92.77, c = 77.06 A˚,  = 121.66. Specific volume calculations based
on the molecular weight of CRD_SIGNR-1 and the unit-cell para-
meters indicated the presence of four molecules in the asymmetric
unit with 64% solvent content and a Matthews coefficient VM of
3.49 A˚3 Da1 (Matthews, 1968). Structure determination was initi-
ated using the human DC-SIGN structure (PDB code 1k9j; Feinberg
et al., 2001), which shows 68% sequence identity, as the initial
structural model. Molecular replacement was performed with the
MOLREP program (Vagin & Teplyakov, 1997) using reflections to
3.5 A˚ resolution. Four single and unambiguous solutions for the
rotation and translation functions were obtained, which yielded a
final correlation coefficient of 0.60 and an R factor of 0.49. The space
group was confirmed to be C2, with four monomers in the asymmetric
unit. Structural refinement of the CRD_SIGNR-1 model is currently
in progress.
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Table 1
Data-collection statistics for CRD_SIGN-R1 crystals.
Values in parentheses are for the highest resolution shell.
Crystal data
Space group C2
Unit-cell parameters
a (A˚) 146.72
b (A˚) 92.77
c (A˚) 77.06
 () 121.66
Data collection
Temperature (K) 100
Wavelength (A˚) 1.07225
Resolution (A˚) 74.58–1.87 (1.97–1.87)
Unique data 52474 (2478)
Multiplicity 3.9 (2.8)
Data completeness (%) 93.30 (72.54)
Average I/(I) 11.80 (1.70)
Molecules per ASU 4
Matthews coefficient (A˚3 Da1) 3.49
Solvent content (%) 64.73
Rmerge† 0.06 (0.57)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith measure-
ment of reflection hkl and hI(hkl)i is the weighted mean of all measurements.
